Roivant Sciences Ltd. Common Shares vs SK Hynix — how do they compare? Roivant Sciences Ltd. Common Shares trades at $35.16 (market cap $24.72B), while SK Hynix trades at $170.56 (market cap $891.31B). The key difference: SK Hynix is far larger — about 36.1× Roivant Sciences Ltd. Common Shares's market cap, and SK Hynix pays a 0.06% dividend while Roivant Sciences Ltd. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Roivant Sciences Ltd. Common Shares for 0 Days and SK Hynix for 10 Days on average.
| ROIV | SKHY | |
|---|---|---|
Market Cap | $24.72B | $891.31B |
Volume | 6,279,442 | 22,268,296 |
Sector | Health | Technology |
52-Week High | $41.81 | $198.63 |
52-Week Low | $16.04 | $126.79 |
Typical Hold Time | 0 Days | 10 Days |
Enterprise Value | $20.99B | $841.45B |
Dividend Yield | — | 0.06% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →SK hynix is a South Korean semiconductor company that manufactures memory products, including DRAM and NAND flash. Its high-bandwidth memory (HBM) products are designed for high-performance computing and AI applications.
Read more on SKHY →